Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China
Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 3...
Saved in:
Published in | International journal of epidemiology Vol. 52; no. 6; pp. 1805 - 1814 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
25.12.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0300-5771 1464-3685 1464-3685 |
DOI | 10.1093/ije/dyad100 |
Cover
Loading…
Abstract | Abstract
Background
Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.
Methods
Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.
Results
Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.
Conclusions
The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer. |
---|---|
AbstractList | Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.
Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.
Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.
The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer. Abstract Background Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016. Methods Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups. Results Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors. Conclusions The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer. Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.BACKGROUNDUnderstanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer prevention and control. In this study, we estimated the population attributable fractions (PAFs) of liver cancer in all 31 provinces of China in 2016.Prevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.METHODSPrevalence estimates of risk factors were derived from representative surveys. We used pooled relative risks obtained from several recent large-scale pooled analyses or high-quality meta-analyses. We calculated PAFs using multiple formulas which included exposure prevalence and relative risk data stratified by sex, age and province, and then combined and created overall PAFs by sex, risk factors and risk factor groups.Approximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.RESULTSApproximately 252 046 liver cancer cases {69.5% [95% confidence interval (CI) 52.6, 76.5]} and 212 704 deaths [67.7% (95% CI 50.9, 74.6)] were attributable to modifiable risk factors in China in 2016. The overall PAF for liver cancer was approximately 1.5 times higher in men than in women, with the top three risk factors in men being hepatitis B virus (HBV), smoking and alcohol drinking, whereas in women, they were HBV, excess body weight and hepatitis C virus (HCV). Among the risk factor groups, infectious agents had the highest PAF, followed by behavioural factors and metabolic factors.The PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer.CONCLUSIONSThe PAF for liver cancer caused by modifiable risk factors varies widely among provinces and socioeconomic and geographical regions in China. The use of tailored primary prevention strategies across provinces and socioeconomic and geographical regions has great potential to reduce the burden and disparities of liver cancer. |
Author | Lin, Yushi Zheng, Luyan Zheng, Yang Wu, Jie Fang, Kailu Zheng, Min |
Author_xml | – sequence: 1 givenname: Yushi surname: Lin fullname: Lin, Yushi – sequence: 2 givenname: Luyan surname: Zheng fullname: Zheng, Luyan email: minzheng@zju.edu.cn – sequence: 3 givenname: Kailu surname: Fang fullname: Fang, Kailu – sequence: 4 givenname: Yang surname: Zheng fullname: Zheng, Yang email: minzheng@zju.edu.cn – sequence: 5 givenname: Jie surname: Wu fullname: Wu, Jie – sequence: 6 givenname: Min orcidid: 0000-0001-6159-9879 surname: Zheng fullname: Zheng, Min email: minzheng@zju.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37431632$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtLAzEQgIMoWh8n75KTCLJ2ssk-epTiCwQ99L5kk1ka3SZrkhX67422ehD0MjMw3wwz3yHZtc4iIacMrhjM-NS84FSvpWYAO2TCRCkyXtbFLpkAB8iKqmIH5DCEFwAmhJjtkwNeCc5Knk_I8tm7wflonKWuo715R0-VtOorBQxUWk01yrhMZYzetGOUbY80Ojq4iDYa2fdrunLadOar4014pZ1U0flAjaXzpbHymOx1sg94ss1HZHF7s5jfZ49Pdw_z68dM8RxipotWsXR-XnClK6zrvK065KBRKAWaVTPGVJl-ystKQQp5atWqwBlwVSE_IhebtYN3byOG2KxMUNj30qIbQ5PXhRAcRAEJPduiY7tC3QzerKRfN99yEnC5AZR3IXjsfhAGzaf6JqlvtuoTzX7RykT5KTZ6afo_Zs43M24c_l3-Ac20lk0 |
CitedBy_id | crossref_primary_10_14309_ajg_0000000000002778 crossref_primary_10_1002_ijc_35233 crossref_primary_10_12677_jcpm_2024_34324 crossref_primary_10_1007_s00262_024_03917_w crossref_primary_10_1016_j_ejon_2024_102660 crossref_primary_10_3389_fpubh_2025_1523578 crossref_primary_10_2196_55657 crossref_primary_10_1007_s11912_024_01605_7 |
Cites_doi | 10.1111/j.1360-0443.2011.03514.x 10.1186/1471-2458-12-967 10.1177/00368504211018081 10.1111/j.1349-7006.2009.01458.x 10.1210/jc.2008-1595 10.3322/caac.21440 10.1016/j.ijid.2011.10.009 10.1136/tobaccocontrol-2015-052534 10.1158/1940-6207.CAPR-13-0168 10.3109/23744235.2015.1064541 10.1186/s12879-019-4428-y 10.1016/j.jhep.2022.08.021 10.5993/AJHB.44.6.4 10.1001/jamaoncol.2018.5639 10.1016/j.vaccine.2009.08.048 10.1093/annonc/mdx342 10.1038/nrendo.2011.183 10.1016/j.diabres.2010.11.002 10.1001/jama.2013.168118 10.1038/s41574-019-0176-8 10.1016/S0140-6736(13)61097-1 10.1161/CIRCULATIONAHA.108.788166 10.1136/bmj.g7607 10.1371/journal.pone.0204221 10.1016/S2213-2600(18)30432-6 10.1093/ofid/ofz040 10.35772/ghm.2021.01037 10.1016/j.canep.2016.06.013 10.21147/j.issn.1000-9604.2017.03.11 10.21147/j.issn.1000-9604.2021.04.05 10.1002/ijc.21731 10.1016/S2214-109X(15)70017-3 10.1016/j.eclinm.2020.100521 10.1016/j.semcancer.2010.11.002 10.1371/journal.pntd.0005239 10.1093/annonc/mds139 10.1038/ajg.2013.160 10.3390/nu14051027 10.1016/S2214-109X(18)30488-1 10.1002/ijc.31088 10.1016/S2214-109X(21)00517-9 |
ContentType | Journal Article |
Copyright | The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 2023 The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association. |
Copyright_xml | – notice: The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association 2023 – notice: The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/ije/dyad100 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1464-3685 |
EndPage | 1814 |
ExternalDocumentID | 37431632 10_1093_ije_dyad100 10.1093/ije/dyad100 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 71904170 – fundername: Zhejiang University – fundername: K. P. Chao's High Technology Development Foundation grantid: 2022RC017 – fundername: Zhejiang University K. P. Chao's High Technology Development Foundation grantid: 2022RC017 – fundername: Technological Innovation Leading Talents of "Ten Thousand Talents Plan" of Zhejiang Province grantid: 2020R52010 – fundername: Mega-Project of National Science and Technology for the 13th Five-Year Plan of China grantid: 2018ZX10721102-003-006 |
GroupedDBID | --- -E4 .2P .GJ .I3 .ZR 0R~ 18M 1TH 29J 2WC 354 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D A8Z AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT AAYJJ ABDFA ABEHJ ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQTQ ABSMQ ABVGC ABWST ABXVV ABYLZ ABZBJ ACFRR ACGFO ACGFS ACIWK ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACVHY ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFCKW AFFNX AFFQV AFFZL AFIYH AFOFC AFRAH AFSHK AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGQZG AGSYK AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AMHCJ APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BWUDY BZKNY C1A C45 CAG CDBKE CNZYI COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD EMOBN F5P F9B FEDTE FLUFQ FOEOM FOTVD FQBLK FTKQU GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M49 MBLQV N9A NGC NOMLY NOYVH NPJNY NTWIH NU- NVLIB O0~ O9- OAWHX OBFPC OBS OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TEORI TJX TMA TR2 VH1 W2D W8F WH7 WOQ X7H YAYTL YHZ YKOAZ YSK YXANX ZGI ZKX ZXP ~91 AAYXX AGORE AHGBF AJBYB CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c320t-d5bc1368253cd7e882b7fe30de4cc0d17911c6577267c026720de8c5e903c7e3 |
ISSN | 0300-5771 1464-3685 |
IngestDate | Fri Jul 11 15:24:07 EDT 2025 Mon Jul 21 05:57:07 EDT 2025 Tue Jul 01 01:59:11 EDT 2025 Thu Apr 24 22:59:23 EDT 2025 Wed Apr 02 07:03:59 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Liver cancer risk factor China prevention population attributable fraction |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights) https://academic.oup.com/pages/standard-publication-reuse-rights The Author(s) 2023; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c320t-d5bc1368253cd7e882b7fe30de4cc0d17911c6577267c026720de8c5e903c7e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6159-9879 |
PMID | 37431632 |
PQID | 2854430450 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2854430450 pubmed_primary_37431632 crossref_primary_10_1093_ije_dyad100 crossref_citationtrail_10_1093_ije_dyad100 oup_primary_10_1093_ije_dyad100 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-12-25 |
PublicationDateYYYYMMDD | 2023-12-25 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | International journal of epidemiology |
PublicationTitleAlternate | Int J Epidemiol |
PublicationYear | 2023 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Wang (2023122523574178700_dyad100-B49) 2020; 26 Gao (2023122523574178700_dyad100-B22) 2019; 6 Islami (2023122523574178700_dyad100-B28) 2018; 68 International Agency for Research on Cancer (IARC) (2023122523574178700_dyad100-B16) 2022 Hu (2023122523574178700_dyad100-B36) 2016; 25 Shi (2023122523574178700_dyad100-B47) 2011; 91 International Agency for Research on Cancer (2023122523574178700_dyad100-B2) 2020 Tsilidis (2023122523574178700_dyad100-B18) 2015; 350 Su (2023122523574178700_dyad100-B41) 2022; 10 Chen (2023122523574178700_dyad100-B25) 2012; 25 Tang (2023122523574178700_dyad100-B45) 2020; 44 National Statistical Office (2023122523574178700_dyad100-B29) 2011 Luo (2023122523574178700_dyad100-B39) 2012; 16 Lai (2023122523574178700_dyad100-B24) 2017; 11 Parkin (2023122523574178700_dyad100-B27) 2006; 118 Chen (2023122523574178700_dyad100-B7) 2013; 6 Wilson (2023122523574178700_dyad100-B31) 2018; 142 Shin (2023122523574178700_dyad100-B10) 2010; 101 Yu (2023122523574178700_dyad100-B1) 2021; 104 Misra (2023122523574178700_dyad100-B48) 2008; 93 Chen (2023122523574178700_dyad100-B5) 2011; 21 Li (2023122523574178700_dyad100-B35) 2011; 106 Wang (2023122523574178700_dyad100-B33) 2019; 7 Whiteman (2023122523574178700_dyad100-B11) 2016; 44 Wang (2023122523574178700_dyad100-B40) 2019; 19 Wu (2023122523574178700_dyad100-B26) 2008; 118 Wang (2023122523574178700_dyad100-B46) 2012; 12 Welzel (2023122523574178700_dyad100-B6) 2013; 108 Rumgay (2023122523574178700_dyad100-B9) 2022; 77 National Central Cancer (2023122523574178700_dyad100-B19) 2022 Islami (2023122523574178700_dyad100-B44) 2019; 5 Xu (2023122523574178700_dyad100-B14) 2018; 13 World Cancer Research Fund/American Institute for Cancer Research (2023122523574178700_dyad100-B17) 2018 WHO Regional Office for the Western Pacific (2023122523574178700_dyad100-B37) 2014 Islami (2023122523574178700_dyad100-B12) 2017; 28 Chen (2023122523574178700_dyad100-B21) 2011; 32 Wang (2023122523574178700_dyad100-B13) 2012; 23 Bluher (2023122523574178700_dyad100-B42) 2019; 15 Liang (2023122523574178700_dyad100-B20) 2009; 27 Xu (2023122523574178700_dyad100-B34) 2013; 310 Chen (2023122523574178700_dyad100-B30) 2019; 7 Inoue (2023122523574178700_dyad100-B32) 2022; 4 Chen (2023122523574178700_dyad100-B43) 2011; 8 Yang (2023122523574178700_dyad100-B3) 2013; 381 Chen (2023122523574178700_dyad100-B8) 2022; 14 Cai (2023122523574178700_dyad100-B4) 2017; 29 Zhang (2023122523574178700_dyad100-B23) 2015; 47 Cao (2023122523574178700_dyad100-B15) 2021; 33 Jiang (2023122523574178700_dyad100-B38) 2015; 3 |
References_xml | – volume: 106 start-page: 1946 year: 2011 ident: 2023122523574178700_dyad100-B35 article-title: Drinking behaviour among men and women in China: the 2007 China chronic disease and risk factor surveillance publication-title: Addiction doi: 10.1111/j.1360-0443.2011.03514.x – volume: 12 start-page: 967 year: 2012 ident: 2023122523574178700_dyad100-B46 article-title: Epidemiology of general obesity, abdominal obesity and related risk factors in urban adults from 33 communities of Northeast China: the CHPSNE study publication-title: BMC Public Health doi: 10.1186/1471-2458-12-967 – volume: 104 start-page: 368504211018081 year: 2021 ident: 2023122523574178700_dyad100-B1 article-title: Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019: an age-period-cohort analysis publication-title: Sci Prog doi: 10.1177/00368504211018081 – volume: 101 start-page: 579 year: 2010 ident: 2023122523574178700_dyad100-B10 article-title: Epidemiology of cholangiocarcinoma: an update focusing on risk factors publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2009.01458.x – year: 2022 ident: 2023122523574178700_dyad100-B16 – volume: 93 start-page: S9 year: 2008 ident: 2023122523574178700_dyad100-B48 article-title: Obesity and the metabolic syndrome in developing countries publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-1595 – volume: 68 start-page: 31 year: 2018 ident: 2023122523574178700_dyad100-B28 article-title: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States publication-title: CA Cancer J Clin doi: 10.3322/caac.21440 – volume: 16 start-page: e82 year: 2012 ident: 2023122523574178700_dyad100-B39 article-title: Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2011.10.009 – volume: 25 start-page: 609 year: 2016 ident: 2023122523574178700_dyad100-B36 article-title: China has raised the tax on cigarettes: what's next? publication-title: Tob Control doi: 10.1136/tobaccocontrol-2015-052534 – volume: 6 start-page: 1038 year: 2013 ident: 2023122523574178700_dyad100-B7 article-title: Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-13-0168 – volume: 47 start-page: 878 year: 2015 ident: 2023122523574178700_dyad100-B23 article-title: A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1–59 years publication-title: Infect Dis (Lond) doi: 10.3109/23744235.2015.1064541 – volume: 19 start-page: 811 year: 2019 ident: 2023122523574178700_dyad100-B40 article-title: Hepatitis B infection in the general population of China: a systematic review and meta-analysis publication-title: BMC Infect Dis doi: 10.1186/s12879-019-4428-y – volume: 77 start-page: 1598 year: 2022 ident: 2023122523574178700_dyad100-B9 article-title: Global burden of primary liver cancer in 2020 and predictions to 2040 publication-title: J Hepatol doi: 10.1016/j.jhep.2022.08.021 – volume: 44 start-page: 780 year: 2020 ident: 2023122523574178700_dyad100-B45 article-title: Differences in overweight and obesity between the north and south of China publication-title: Am J Health Behav doi: 10.5993/AJHB.44.6.4 – volume: 5 start-page: 384 year: 2019 ident: 2023122523574178700_dyad100-B44 article-title: Proportion of cancer cases attributable to excess body weight by US State, 2011-2015 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2018.5639 – year: 2022 ident: 2023122523574178700_dyad100-B19 – year: 2020 ident: 2023122523574178700_dyad100-B2 – volume: 27 start-page: 6550 year: 2009 ident: 2023122523574178700_dyad100-B20 article-title: Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination publication-title: Vaccine doi: 10.1016/j.vaccine.2009.08.048 – year: 2011 ident: 2023122523574178700_dyad100-B29 – volume: 28 start-page: 2567 year: 2017 ident: 2023122523574178700_dyad100-B12 article-title: Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013 publication-title: Ann Oncol doi: 10.1093/annonc/mdx342 – volume: 8 start-page: 228 year: 2011 ident: 2023122523574178700_dyad100-B43 article-title: The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2011.183 – volume: 25 start-page: 163 year: 2012 ident: 2023122523574178700_dyad100-B25 article-title: Analysis of the results of two nationwide surveys on Clonorchis sinensis infection in China publication-title: Biomed Environ Sci – volume: 91 start-page: 389 year: 2011 ident: 2023122523574178700_dyad100-B47 article-title: Prevalence of obesity and associated risk factors in Northeastern China publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2010.11.002 – volume: 310 start-page: 948 year: 2013 ident: 2023122523574178700_dyad100-B34 article-title: Prevalence and control of diabetes in Chinese adults publication-title: JAMA doi: 10.1001/jama.2013.168118 – volume: 15 start-page: 288 year: 2019 ident: 2023122523574178700_dyad100-B42 article-title: Obesity: global epidemiology and pathogenesis publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-019-0176-8 – volume: 381 start-page: 1987 year: 2013 ident: 2023122523574178700_dyad100-B3 article-title: Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(13)61097-1 – volume: 118 start-page: 2679 year: 2008 ident: 2023122523574178700_dyad100-B26 article-title: Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.788166 – volume: 350 start-page: g7607 year: 2015 ident: 2023122523574178700_dyad100-B18 article-title: Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies publication-title: BMJ doi: 10.1136/bmj.g7607 – volume: 13 start-page: e0204221 year: 2018 ident: 2023122523574178700_dyad100-B14 article-title: Cancer mortality attributable to cigarette smoking in 2005, 2010 and 2015 in Qingdao, China publication-title: PLoS One doi: 10.1371/journal.pone.0204221 – volume: 7 start-page: 35 year: 2019 ident: 2023122523574178700_dyad100-B33 article-title: Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(18)30432-6 – volume: 6 start-page: ofz040 year: 2019 ident: 2023122523574178700_dyad100-B22 article-title: Prevalence of anti-HCV antibody among the general population in mainland China between 1991 and 2015: a systematic review and meta-analysis publication-title: Open Forum Infect Dis doi: 10.1093/ofid/ofz040 – volume: 4 start-page: 26 year: 2022 ident: 2023122523574178700_dyad100-B32 article-title: Burden of cancer attributable to modifiable factors in Japan in 2015 publication-title: Glob Health Med doi: 10.35772/ghm.2021.01037 – volume: 44 start-page: 203 year: 2016 ident: 2023122523574178700_dyad100-B11 article-title: The fractions of cancer attributable to modifiable factors: a global review publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2016.06.013 – year: 2014 ident: 2023122523574178700_dyad100-B37 – year: 2018 ident: 2023122523574178700_dyad100-B17 – volume: 29 start-page: 253 year: 2017 ident: 2023122523574178700_dyad100-B4 article-title: Expenditure of hospital care on cancer in China, from 2011 to 2015 publication-title: Chin J Cancer Res doi: 10.21147/j.issn.1000-9604.2017.03.11 – volume: 33 start-page: 480 year: 2021 ident: 2023122523574178700_dyad100-B15 article-title: Attributable deaths of liver cancer in China publication-title: Chin J Cancer Res doi: 10.21147/j.issn.1000-9604.2021.04.05 – volume: 118 start-page: 3030 year: 2006 ident: 2023122523574178700_dyad100-B27 article-title: The global health burden of infection-associated cancers in the year 2002 publication-title: Int J Cancer doi: 10.1002/ijc.21731 – volume: 3 start-page: e190 year: 2015 ident: 2023122523574178700_dyad100-B38 article-title: Alcohol and related health issues in China: action needed publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(15)70017-3 – volume: 26 start-page: 100521 year: 2020 ident: 2023122523574178700_dyad100-B49 article-title: Prevalence and changes of BMI categories in China and related chronic diseases: Cross-sectional National Health Service Surveys (NHSSs) from 2013 to 2018 publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100521 – volume: 21 start-page: 59 year: 2011 ident: 2023122523574178700_dyad100-B5 article-title: Liver cancer epidemic in China: past, present and future publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2010.11.002 – volume: 11 start-page: e0005239 year: 2017 ident: 2023122523574178700_dyad100-B24 article-title: Risk mapping of clonorchiasis in the People's Republic of China: a systematic review and Bayesian geostatistical analysis publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0005239 – volume: 23 start-page: 2983 year: 2012 ident: 2023122523574178700_dyad100-B13 article-title: Attributable causes of cancer in China publication-title: Ann Oncol doi: 10.1093/annonc/mds139 – volume: 32 start-page: 888 year: 2011 ident: 2023122523574178700_dyad100-B21 article-title: A sero-epidemiological study on hepatitis C in China publication-title: Zhonghua Liu Xing Bing Xue Za Zhi – volume: 108 start-page: 1314 year: 2013 ident: 2023122523574178700_dyad100-B6 article-title: Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States publication-title: Am J Gastroenterol doi: 10.1038/ajg.2013.160 – volume: 14 start-page: 1027 year: 2022 ident: 2023122523574178700_dyad100-B8 article-title: Burden of disease associated with dietary exposure to aflatoxins in China in 2020 publication-title: Nutrients doi: 10.3390/nu14051027 – volume: 7 start-page: e257 year: 2019 ident: 2023122523574178700_dyad100-B30 article-title: Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(18)30488-1 – volume: 142 start-page: 691 year: 2018 ident: 2023122523574178700_dyad100-B31 article-title: How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013 publication-title: Int J Cancer doi: 10.1002/ijc.31088 – volume: 10 start-page: e278 year: 2022 ident: 2023122523574178700_dyad100-B41 article-title: Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(21)00517-9 |
SSID | ssj0014449 |
Score | 2.4850874 |
Snippet | Abstract
Background
Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and... Understanding the differences in the burden of liver cancer due to different risk factors across provinces is critical to informing and improving liver cancer... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1805 |
SubjectTerms | Alcohol Drinking - adverse effects Alcohol Drinking - epidemiology China - epidemiology Female Hepatitis C - epidemiology Humans Liver Neoplasms - epidemiology Liver Neoplasms - etiology Male Risk Factors Smoking - adverse effects Smoking - epidemiology Weight Gain |
Title | Proportion of liver cancer cases and deaths attributable to potentially modifiable risk factors in China |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37431632 https://www.proquest.com/docview/2854430450 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZtCiEQQpu-0vShQk4FJ7Yl27vHEJqGNik9bGFzMrIkExfXXrL2YfPrOyPJj2XT0vYiG0trgb9vxzPjeRByBCYyy2OtvBy0AY9zoT0hAukFIs7hbchlqNE1cPU1vvjOP8-j-eiLKWaXNNmxvLs3r-R_UIVrgCtmyf4Dsv1N4QKcA74wAsIw_hXG37DFwW2n85UYYoFRXNIcltqWX1ao5MFpY3tbmVQpUDgXdYOBQqIsV9gOp8gLM2NCzbsmPJgR2PXX7jTYdRfiqPCEHnrN9m76S1uh4Lpd3hSDi1pb-XLZrgZqnju_9RdRlO3G0mvhXrDOPxEyjPWwuczH2spUHnMP69yPhW4Ujsg1lqDBxKRhb4p2W_aq-KFhVCuhAlPhtBnBvPhpcGaoFMXOa7peS7ubekgehWBWoCD_NO9DgsC25FOXwwm7ncBeJ26nHbLd_XZNgVlLitywTYyOMntM9pxxQU8tU56QB7raJ9tXLnxin-xaJy21uWdPyc1AIFrn1BCIWgJRQyAKBKKWQHRMINrUdEQgOhCIIoGoIxAtKmoI9IzMzj_Ozi4813rDkyz0G09FmQwAszBiUiUazLAsyTXzleZS-gpr2gYyjuAZxonEJmYhTE1kpKc-k4lmz8lWVVf6JaGcKTaNfMlZznmSsKlKooRlLMgUGPuT5IB86B5nKl1ZeuyOUqY2PIKlAEPqYDggR_3iha3Gcv-yd4DLn1e87zBLQZ7iRzJR6bpdpphRzDF8ANa8sGD2N-oo8Oq3M4dkZ_gPvCZbzW2r34DW2mRvDdV-AbklnDA |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proportion+of+liver+cancer+cases+and+deaths+attributable+to+potentially+modifiable+risk+factors+in+China&rft.jtitle=International+journal+of+epidemiology&rft.au=Lin%2C+Yushi&rft.au=Zheng%2C+Luyan&rft.au=Fang%2C+Kailu&rft.au=Zheng%2C+Yang&rft.date=2023-12-25&rft.eissn=1464-3685&rft.volume=52&rft.issue=6&rft.spage=1805&rft_id=info:doi/10.1093%2Fije%2Fdyad100&rft_id=info%3Apmid%2F37431632&rft.externalDocID=37431632 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-5771&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-5771&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-5771&client=summon |